INS and psychiatric disorder: Cases used significantly more insulin, glucagon-like peptide-1 (GLP-1) receptor analogs, antibiotics, steroids (systemic and local), opioids, non-steroidal anti-inflammatory agents (NSAIDs), and medications for respiratory, cardiac, gastrointestinal, and psychiatric disorders.